科兴制药与IQVIA艾昆纬达成战略合作

Core Viewpoint - The company, Sinovac Biotech, has established a comprehensive strategic partnership with IQVIA to enhance the clinical design, registration, and commercialization of its innovative drugs and biosimilars in Europe and globally [1] Group 1 - The partnership aims to leverage the strengths of both companies to advance the development of Sinovac's products [1] - The collaboration will focus on the clinical design and registration processes, indicating a commitment to regulatory compliance and market readiness [1] - The strategic alliance is expected to facilitate the commercialization of Sinovac's innovative drugs and biosimilars, potentially increasing market access and revenue opportunities [1]